Eli Lilly, Nimbus Partner to Develop, License Oral Obesity Treatment

Eli Lilly and Nimbus Therapeutics have entered into a multiyear collaboration and exclusive licensing agreement to develop an oral treatment for obesity and other metabolic diseases.